Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.

K. Beelen; M. Opdam; T.M. Severson; R.H.T. Koornstra; A.D. Vincent; J. Wesseling; J.J. Muris; E.M.J.J. Berns; J.B. Vermorken; P.J. van Diest; S.C. Linn

Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.

Translated title of the contribution: Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.

K. Beelen, M. Opdam, T.M. Severson, R.H.T. Koornstra, A.D. Vincent, J. Wesseling, J.J. Muris, E.M.J.J. Berns, J.B. Vermorken, P.J. van Diest, S.C. Linn

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.
Original language	Undefined/Unknown
Pages (from-to)	R6
Number of pages	1
Journal	Breast Cancer Research
Volume	16
Issue number	1
Publication status	Published - 2014

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/24447434

Cite this

Beelen, K., Opdam, M., Severson, T. M., Koornstra, R. H. T., Vincent, A. D., Wesseling, J., Muris, J. J., Berns, E. M. J. J., Vermorken, J. B., van Diest, P. J., & Linn, S. C. (2014). Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment. Breast Cancer Research, 16(1), R6. http://www.ncbi.nlm.nih.gov/pubmed/24447434

@article{b5b537fc84004fe0ba55367927ee9cec,

title = "Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.",

author = "K. Beelen and M. Opdam and T.M. Severson and R.H.T. Koornstra and A.D. Vincent and J. Wesseling and J.J. Muris and E.M.J.J. Berns and J.B. Vermorken and {van Diest}, P.J. and S.C. Linn",

year = "2014",

language = "Undefined/Unknown",

volume = "16",

pages = "R6",

journal = "Breast Cancer Research",

issn = "1465-5411",

publisher = "BioMed Central Ltd.",

number = "1",

}

Beelen, K, Opdam, M, Severson, TM, Koornstra, RHT, Vincent, AD, Wesseling, J, Muris, JJ, Berns, EMJJ, Vermorken, JB, van Diest, PJ & Linn, SC 2014, 'Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.', Breast Cancer Research, vol. 16, no. 1, pp. R6. <http://www.ncbi.nlm.nih.gov/pubmed/24447434>

TY - JOUR

T1 - Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.

AU - Beelen, K.

AU - Opdam, M.

AU - Severson, T.M.

AU - Koornstra, R.H.T.

AU - Vincent, A.D.

AU - Wesseling, J.

AU - Muris, J.J.

AU - Berns, E.M.J.J.

AU - Vermorken, J.B.

AU - van Diest, P.J.

AU - Linn, S.C.

PY - 2014

Y1 - 2014

M3 - Article

SN - 1465-5411

VL - 16

SP - R6

JO - Breast Cancer Research

JF - Breast Cancer Research

IS - 1

ER -